The Autoinjectors Market is expected to witness a growth rate of 14-16% by 2028. The key factors driving the market are the ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $219.8, along ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The siRNA technology has has the potential to enable sustained and precise messenger RNA silencing, regulating the expression ...

The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.